OTPilotJournal of neuroengineering and rehabilitation2019

Home used, patient self-managed, brain-computer interface for the management of central neuropathic pain post spinal cord injury: usability study.

M K H Al-Taleb, M Purcell, M Fraser and 2 others

PMID 31666096

WHAT IT FOUND

People with spinal cord injury and chronic central pain could self-manage a home neurofeedback headset, but eight of fifteen who tried it stopped.

Twelve reported lower pain, and eight had a drop larger than 30%. This was not a controlled test.

Key findings

01Fifteen of the twenty recruited participants used the home system, all learned to self-manage it, but eight discontinued and only seven used it for the required two months.

02Among the fifteen home users, twelve had pain scores the authors reported as lower beyond chance, and eight had a reduction larger than 30%.

03Nine participants rated satisfaction 4.5 out of 5 for the device and 4.9 out of 5 for the service.

STILL TO COME

How it was doneWhat they foundWhat it means for OTs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

The study had no control group, no blinding and no placebo test, so pain changes cannot be attributed to neurofeedback alone. Participants continued their prescribed pain medications, and some needed caregiver-assisted setup, so the contribution of neurofeedback cannot be separated from those supports. Only fifteen of twenty recruited participants used the home system, eight discontinued, and only seven used it for the required two months. Only nine participants completed the final interviews and user-experience questionnaires, and six participants did not answer some usability questions. The participants were described as early adopters of technology, so their satisfaction and commitment may not apply to a wider group. EEG was recorded from a single electrode with a consumer headset not designed for the central cortex, and 10 to 20% of home EEG data was noisy. Side effects such as reduced spasm or improved sleep were reported in interviews but were not systematically measured.

Declared interests

Funding came from Research Councils UK and the Inspire Foundation.

The easy way to misread this

Do not conclude that neurofeedback alone reduced central neuropathic pain. Participants also used prescribed pain medications and some needed caregiver-assisted setup, and the study had no control group, no blinding and no placebo test.

Read it on PubMed →